ASH elects three to leadership positions

Jane Winter
Jane Winter

ASH announced the election of three clinicians to leadership positions within the society.

Jane Winter, MD, will serve a 1-year term as vice president, followed by successive terms as president-elect and president.

Alison Loren, MD, MSCE, and Bob Löwenberg, MD, PhD, each will serve 4-year terms as councillors.

Winter, Loren and Löwenberg will begin their service after this year’s ASH Annual Meeting and Exposition, which will be held Dec. 7-10 in Orlando.

“Drs. Winter, Loren, and Löwenberg have been longstanding members of ASH and have demonstrated leadership and dedication to various ASH committees and publications throughout their years of service,” ASH President Roy L. Silverstein, MD, chairman of the department of medicine at Medical College of Wisconsin, said in a society-issued press release.

“They have greatly contributed to the development of programs that further ASH’s mission, adding tremendous value for hematologists and their patients around the world,” Silverstein added. “Collectively, the perspectives they will bring to the ASH Executive Committee will position the society to take creative advantage of opportunities and address the challenges facing the field in the immediate future and years to come.”

Winter is professor of medicine at Northwestern University’s Feinberg School of Medicine.

Her research interests include clinical and biologic markers of prognosis in diffuse large B-cell lymphoma, as well as clinical trials and translational research with novel agents for non-Hodgkin and Hodgkin lymphoma.

“Never before have there been so many promising scientific advances and new effective therapies in the field of hematology,” Winter said in the release. “As hematologists, we must embrace new constituencies — such as those who work in immunotherapy or vascular biology with whom we share our basic mission — learn from others and always be willing to adapt. I’ve worn many hats throughout my years in the field, and with my help as vice president, all who have an interest in hematology will be welcome under our tent.”

Loren is associate professor of medicine, vice chair for faculty development of the department of medicine, and the director of blood and marrow transplantation at Perelman School of Medicine at University of Pennsylvania. She also is a member of Abramson Cancer Center at Penn.

Her research interests include allogeneic hematopoietic cell transplantation, fertility preservation, cancer survivorship and clinical trials.

Löwenberg is professor of hematology at Erasmus University Rotterdam in the Netherlands, as well as the founding member of International Consortium of Acute Leukemia.

His research interests include molecular and cellular pathobiology of leukemia, as well as developmental diagnostics and therapeutics for leukemia.

Jane Winter
Jane Winter

ASH announced the election of three clinicians to leadership positions within the society.

Jane Winter, MD, will serve a 1-year term as vice president, followed by successive terms as president-elect and president.

Alison Loren, MD, MSCE, and Bob Löwenberg, MD, PhD, each will serve 4-year terms as councillors.

Winter, Loren and Löwenberg will begin their service after this year’s ASH Annual Meeting and Exposition, which will be held Dec. 7-10 in Orlando.

“Drs. Winter, Loren, and Löwenberg have been longstanding members of ASH and have demonstrated leadership and dedication to various ASH committees and publications throughout their years of service,” ASH President Roy L. Silverstein, MD, chairman of the department of medicine at Medical College of Wisconsin, said in a society-issued press release.

“They have greatly contributed to the development of programs that further ASH’s mission, adding tremendous value for hematologists and their patients around the world,” Silverstein added. “Collectively, the perspectives they will bring to the ASH Executive Committee will position the society to take creative advantage of opportunities and address the challenges facing the field in the immediate future and years to come.”

Winter is professor of medicine at Northwestern University’s Feinberg School of Medicine.

Her research interests include clinical and biologic markers of prognosis in diffuse large B-cell lymphoma, as well as clinical trials and translational research with novel agents for non-Hodgkin and Hodgkin lymphoma.

“Never before have there been so many promising scientific advances and new effective therapies in the field of hematology,” Winter said in the release. “As hematologists, we must embrace new constituencies — such as those who work in immunotherapy or vascular biology with whom we share our basic mission — learn from others and always be willing to adapt. I’ve worn many hats throughout my years in the field, and with my help as vice president, all who have an interest in hematology will be welcome under our tent.”

Loren is associate professor of medicine, vice chair for faculty development of the department of medicine, and the director of blood and marrow transplantation at Perelman School of Medicine at University of Pennsylvania. She also is a member of Abramson Cancer Center at Penn.

Her research interests include allogeneic hematopoietic cell transplantation, fertility preservation, cancer survivorship and clinical trials.

Löwenberg is professor of hematology at Erasmus University Rotterdam in the Netherlands, as well as the founding member of International Consortium of Acute Leukemia.

His research interests include molecular and cellular pathobiology of leukemia, as well as developmental diagnostics and therapeutics for leukemia.